Pharma News

A new clinical study has reported encouraging results for Foralumab, an experimental nasal treatment designed to reduce inflammation in patients with progressive multiple sclerosis (MS). The findings suggest that this innovative approach could offer new possibilities for managing certain forms of the disease. Tiziana Life Sciences, a biotechnology company developing immunomodulatory therapies, announced positive preliminary results from its Phase 2a clinical trial, known as INFORM-MS. The study evaluated the safety and...

A major international study suggests that a simple blood test measuring a specific biological marker associated with Alzheimer's disease could help identify older adults at increased risk of developing cognitive impairment up to a decade before noticeable symptoms emerge. The research, led by scientists at the Mass General Brigham Neuroscience Institute in the United States, represents an important step toward understanding how blood-based biomarkers may improve the early identification of...

Olive Oil and Blood Pressure: Three Potential Pathways Supporting Heart Health Extra virgin olive oil, due to its high content of beneficial compounds such as unsaturated fats, particularly monounsaturated fatty acids, as well as polyphenols, is considered one of the key components of dietary patterns associated with cardiovascular health. Scientific evidence suggests that regular consumption of extra virgin olive oil may help maintain blood pressure within a healthy range and...

Regeneron's Experimental Drug Combination May Help Preserve Muscle Mass During Weight Loss Treatment According to new data scheduled to be presented at a medical meeting, the experimental weight-loss drug trevogrumab developed by Regeneron, when combined with semaglutide from Novo Nordisk, has reduced the loss of muscle mass by 50% compared with semaglutide alone in patients with obesity. With the growing popularity of GLP-1-based weight-loss therapies, including semaglutide marketed under the brand...

The Deputy Minister of Health for Treatment Affairs stated that the National Comprehensive Cancer Program will begin in October. All cancer-related services, including insurance coverage, physicians, patients, and health benefactors, will be registered in a dedicated system and documented. According to this program, all cancer patients will receive free services. Speaking on Thursday evening, September 17, during the inauguration ceremony of the advanced Nuclear Medicine Imaging Center (PET Scan) in...